ChemoCentryx's Series B Round

ChemoCentryx raised a round of funding on June 08, 2004.

ChemoCentryx (NASDAQ:CCXI) is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders a…

Articles about ChemoCentryx's Series B Round: